Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
KUNLUN ENERGY
00135
HK Stock MarketDetailed Quotes
SINOPHARM (01099)
- 17.740
- +0.060+0.34%
Trading May 20 15:28 CST
55.36BMarket Cap6.87P/E (TTM)
17.800High17.580Low5.38MVolume17.730Open17.680Prev Close94.91MTurnover0.40%Turnover Ratio6.99P/E (Static)3.12BShares22.34052wk High0.57P/B23.80BFloat Cap17.35052wk Low0.74Dividend TTM1.34BShs Float39.285Historical High0.739Dividend LFY1.24%Range %8.017Historical Low17.647Avg Price400Lot Size4.17%Div Yield TTM4.17%Div Yield LFY
SINOPHARM (01099) Cash Flow
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 5.70%14.8B | ---- | -5.09%7.21B | ---- | -28.25%14B | ---- | -14.32%7.6B | ---- | 5.11%19.51B |
| Profit adjustment | ||||||||||
| Dividend (income)- adjustment | ---- | -125.49%-9.94M | ---- | 29.66%-396K | ---- | 89.00%-4.41M | ---- | 7.10%-563K | ---- | -206.83%-40.05M |
| Attributable subsidiary (profit) loss | ---- | -2.79%-1.23B | ---- | -10.11%-687.85M | ---- | -8.31%-1.2B | ---- | -8.78%-624.72M | ---- | -3.78%-1.11B |
| Impairment and provisions: | ---- | -34.56%1.68B | ---- | 6.24%1.41B | ---- | 231.98%2.56B | ---- | 0.72%1.33B | ---- | 5.86%772.55M |
| -Other impairments and provisions | ---- | -34.56%1.68B | ---- | 6.24%1.41B | ---- | 231.98%2.56B | ---- | 0.72%1.33B | ---- | 5.86%772.55M |
| Revaluation surplus: | ---- | -87.57%9.73M | ---- | 21.46%-2.48M | ---- | 224.46%78.33M | ---- | -4,251.32%-3.16M | ---- | -377.34%-62.93M |
| -Other fair value changes | ---- | -87.57%9.73M | ---- | 21.46%-2.48M | ---- | 224.46%78.33M | ---- | -4,251.32%-3.16M | ---- | -377.34%-62.93M |
| Asset sale loss (gain): | ---- | -7.87%2.22B | ---- | -15.15%1.1B | ---- | 9.07%2.41B | ---- | -25.42%1.3B | ---- | -57.30%2.21B |
| -Loss (gain) from sale of subsidiary company | ---- | 43.82%-3.1M | ---- | ---- | ---- | 80.14%-5.51M | ---- | -88.32%-9.43M | ---- | -176.25%-27.74M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 3,495.72%6.72M | ---- | 135.09%1.19M | ---- | 100.08%187K | ---- | 96.23%-3.39M | ---- | -1,270.30%-235.93M |
| -Loss (gain) from selling other assets | ---- | -8.22%2.21B | ---- | -16.06%1.1B | ---- | -2.36%2.41B | ---- | -28.57%1.31B | ---- | -52.02%2.47B |
| Depreciation and amortization: | ---- | -9.39%4.29B | ---- | -3.95%2.23B | ---- | 6.85%4.73B | ---- | 10.73%2.33B | ---- | 6.37%4.43B |
| -Depreciation | ---- | -5.82%1.8B | ---- | -3.96%903.84M | ---- | 3.16%1.91B | ---- | 14.50%941.11M | ---- | 3.94%1.86B |
| -Amortization of intangible assets | ---- | 2.87%454.51M | ---- | 3.09%214.85M | ---- | 6.22%441.81M | ---- | -17.39%208.41M | ---- | 6.47%415.93M |
| Special items | ---- | -11.77%-120.81M | ---- | -350.21%-50.09M | ---- | -9.26%-108.08M | ---- | 25.45%-11.13M | ---- | -1.14%-98.92M |
| Operating profit before the change of operating capital | ---- | -3.75%21.63B | ---- | -5.83%11.22B | ---- | -12.26%22.47B | ---- | -11.37%11.91B | ---- | -6.65%25.61B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 45.81%-1.11B | ---- | 49.70%-4.46B | ---- | -547.82%-2.04B | ---- | -45.87%-8.88B | ---- | 104.79%455.56M |
| Accounts receivable (increase)decrease | ---- | 54.49%-7.96B | ---- | 23.91%-44.04B | ---- | -16.98%-17.49B | ---- | 19.14%-57.88B | ---- | -1,578.31%-14.96B |
| Accounts payable increase (decrease) | ---- | 682.80%5.62B | ---- | -62.67%6.02B | ---- | -111.11%-964.07M | ---- | -32.83%16.12B | ---- | -12.40%8.68B |
| prepayments (increase)decrease | ---- | 116.84%1.29B | ---- | -1,194.92%-372.91M | ---- | -87.79%596.23M | ---- | -103.09%-28.8M | ---- | 165.10%4.89B |
| Special items for working capital changes | ---- | -104.44%-595.93M | ---- | -112.33%-57.78M | ---- | 558.41%13.43B | ---- | 132.08%468.49M | ---- | -173.02%-2.93B |
| Cash from business operations | ---- | 17.98%18.88B | ---- | 17.20%-31.7B | ---- | -26.42%16B | ---- | 6.06%-38.29B | ---- | -14.25%21.75B |
| Other taxs | ---- | -6.39%-4.74B | ---- | 10.93%-2.41B | ---- | 2.60%-4.46B | ---- | -5.35%-2.71B | ---- | -4.01%-4.58B |
| Special items of business | 6.15%-32.17B | ---- | 18.11%-39.08B | ---- | 27.81%-34.28B | ---- | -20.29%-47.72B | ---- | -16.68%-47.48B | ---- |
| Net cash from operations | 6.15%-32.17B | 22.45%14.14B | 18.11%-39.08B | 16.79%-34.11B | 27.81%-34.28B | -32.77%11.55B | -20.29%-47.72B | 5.38%-40.99B | -16.68%-47.48B | -18.08%17.17B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -23.64%57.04M | ---- | 0.07%39.75M | ---- | -59.16%74.7M | ---- | 2.72%39.72M | ---- | 145.31%182.9M |
| Dividend received - investment | 328.13%4.68M | -32.28%499.98M | -47.93%149.12M | -68.30%77.67M | -91.29%1.09M | 76.06%738.28M | 67.00%286.4M | 309.39%245.03M | 29.46%12.54M | -25.79%419.34M |
| Restricted cash (increase) decrease | ---- | 97.12%-73.42M | ---- | ---- | ---- | -2,579.71%-2.55B | ---- | -100.27%-4.8M | ---- | 105.83%102.91M |
| Sale of fixed assets | 42.99%3.22M | -70.74%19.23M | -85.51%16.43M | -91.49%7.91M | -94.97%2.26M | -85.59%65.74M | -67.36%113.37M | 85.47%92.91M | 717.81%44.86M | 164.67%456.13M |
| Purchase of fixed assets | -10.43%-354.74M | -1.65%-1.5B | 17.88%-1.14B | 38.75%-626.66M | 32.10%-321.22M | 24.91%-1.47B | -2.26%-1.38B | -42.23%-1.02B | -16.41%-473.1M | 7.88%-1.96B |
| Selling intangible assets | ---- | -91.97%504K | ---- | -95.83%681K | ---- | -97.00%6.28M | ---- | -30.07%16.32M | ---- | 4,467.04%209.08M |
| Purchase of intangible assets | ---- | 75.51%-121.6M | ---- | 86.98%-35.59M | ---- | -31.98%-496.6M | ---- | -98.84%-273.35M | ---- | -29.58%-376.28M |
| Sale of subsidiaries | --15.03M | 35.30%137.13M | ---- | -69.97%13.17M | ---- | 2.17%101.35M | --11.42M | -0.74%43.87M | ---- | -15.40%99.2M |
| Acquisition of subsidiaries | ---- | 96.07%-8.78M | 95.60%-7.42M | ---- | ---- | -70.26%-223.13M | -126.41%-168.44M | -183.82%-103.51M | -271.22%-97.04M | 71.13%-131.05M |
| Recovery of cash from investments | 171.35%37.05M | 269.93%21.76M | -76.00%20.08M | -17.72%274K | -77.30%13.65M | -92.81%5.88M | 161.02%83.66M | -99.65%333K | 380.39%60.16M | -61.41%81.87M |
| Cash on investment | ---59.18M | ---- | 52.48%-9.26M | ---- | ---- | ---- | 78.50%-19.48M | ---41K | 89.33%-4.92M | 99.58%-422K |
| Other items in the investment business | ---- | ---- | 19.99%1.22B | 88.25%-8.44M | 29.16%921.71M | ---- | 3.60%1.01B | -21,939.26%-71.85M | -17.69%713.63M | ---28.64M |
| Net cash from investment operations | -157.32%-353.94M | 74.30%-963.89M | 507.47%250.47M | 48.85%-531.24M | 141.09%617.49M | -297.12%-3.75B | -578.30%-61.47M | -187.97%-1.04B | -38.43%256.12M | 73.69%-944.54M |
| Net cash before financing | 3.38%-32.52B | 69.01%13.17B | 18.74%-38.83B | 17.58%-34.64B | 28.73%-33.66B | -51.97%7.8B | -20.48%-47.78B | 0.27%-42.03B | -17.25%-47.23B | -6.59%16.23B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -6.23%30.55B | 6.93%104.17B | -0.34%89.23B | 11.62%60.83B | -2.45%32.58B | 4.43%97.43B | -7.93%89.54B | -12.12%54.49B | -9.95%33.39B | 4.63%93.29B |
| Refund | -19.95%-21.65B | -11.62%-114.59B | -14.16%-70.66B | -19.75%-42.34B | -1.26%-18.05B | -23.76%-102.66B | 11.02%-61.9B | -1.18%-35.35B | 16.81%-17.83B | 2.07%-82.95B |
| Issuance of bonds | ---- | -60.01%3.8B | ---- | -91.10%800M | ---- | -27.75%9.5B | ---- | 32.23%8.99B | ---- | -23.95%13.15B |
| Interest paid - financing | ---- | 25.51%-2.47B | ---- | -1.16%-1.46B | ---- | -3.86%-3.32B | ---- | -1.64%-1.44B | ---- | 33.05%-3.2B |
| Dividends paid - financing | 22.51%-452.59M | 19.00%-3.36B | 30.12%-4.54B | 32.37%-683.63M | 47.33%-584.07M | 14.09%-4.15B | 13.65%-6.49B | 10.49%-1.01B | 5.31%-1.11B | -20.59%-4.83B |
| Absorb investment income | -52.94%6M | -62.45%48.98M | -68.24%46.73M | -88.05%16.35M | -78.71%12.75M | 7.94%130.45M | 55.82%147.13M | 295.28%136.78M | 330.71%59.88M | -44.51%120.85M |
| Issuance expenses and redemption of securities expenses | ---- | 64.17%-4.3B | ---- | 80.85%-574.4M | ---- | 42.82%-12B | ---- | 66.67%-3B | ---- | -23.43%-20.99B |
| Other items of the financing business | 41.63%-628.22M | ---- | -97.90%-2.54B | ---- | -114.09%-1.08B | 95.16%-5.71M | 50.08%-1.28B | ---- | 15.50%7.64B | -157.47%-118.13M |
| Net cash from financing operations | -39.28%7.82B | -8.11%-18.69B | -42.33%11.54B | -27.71%15.58B | -41.88%12.88B | -126.13%-17.29B | 13.14%20.01B | 1.20%21.55B | 4.94%22.15B | -34.26%-7.64B |
| Effect of rate | -617.95%-7.77M | 6.42%-4.9M | 5.92%-4.48M | -425.58%-11.89M | -266.16%-1.08M | -319.13%-5.24M | -151.47%-4.76M | -33.11%3.65M | 112.76%651.16K | -79.25%2.39M |
| Net Cash | -18.87%-24.7B | 41.91%-5.51B | 1.74%-27.29B | 6.92%-19.06B | 17.11%-20.78B | -210.55%-9.49B | -26.39%-27.77B | 1.77%-20.48B | -30.80%-25.07B | -26.51%8.58B |
| Begining period cash | -10.16%48.8B | -14.88%54.31B | -14.88%54.31B | -14.88%54.31B | -14.88%54.31B | 15.55%63.81B | 15.55%63.81B | 15.55%63.81B | 14.56%63.81B | 26.86%55.22B |
| Cash at the end | -28.17%24.08B | -10.16%48.8B | -25.01%27.02B | -18.68%35.24B | -13.44%33.53B | -14.88%54.31B | 8.34%36.03B | 26.05%43.33B | 6.05%38.74B | 15.55%63.81B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Tianjian International Certified Public Accountants LLP, Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian International Certified Public Accountants LLP, Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PwC, PwC Zhongtian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"